Secondary Outcome: Secondary Outcomes: Changes in waist circumference, body fat, body lean mass, and metabolic risk factors including levels of plasma glucose, insulin sensitivity, serum lipids, and blood pressure Statistical Analysis Full details previously published 2 and can also be found in the STEP group statistical analysis plan at NEJM.org Statistical analysis approach sought strong control for type I error All endpoints addressing intervention efficacy were analyzed using intention-to-treat approach All endpoints addressing intervention safety were analyzed using per-protocol approach Efficacy endpoints analyzed using 2 estimands Treatment Policy Estimand: intention to treat analysis
GLP-1 receptor agonist (Wegovy) The active ingredient in Wegovy is semaglutide , which is a GLP-1 receptor agonist
For most people, calorie deficit bad breath improves as the body adapts to using ketones more efficiently, which can take anywhere from a few days to several weeks
Our clinic offers a full range of advanced surgical and non-surgical treatments designed to support your health, confidence, and long-term weight management goals: All procedures are led by experienced, board-certified surgeons skilled in minimally invasive techniques , ensuring faster recovery, less scarring, and superior outcomes for every patient
PlexusDx providers work collaboratively to tailor your titration pace to your unique physiology and lifestyle
When Should You Stop Semaglutide or Tirzepatide